NASDAQ
Krystal Biotech, Inc. (KRYS) has a free cash flow growth of -2.83% as of Friday, May 29, 2026. This represents a 108.99% decrease compared to its 12-month average of 31.52%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.